Bromelains
- Generic Name
- Bromelains
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 9001-00-7
- Unique Ingredient Identifier
- U182GP2CF3
- Background
Bromelain is a protease enzyme derived from the stems of pineapples that is composed of a mixture of different thiol endopeptidases and other components like phosphatase, glucosidase, peroxidase, cellulase, escharase, and several protease inhibitors . It works by selectively inhibiting the biosynthesis of proinflammatory prostaglandins and also has analgesi...
- Indication
可用于各种原因所致的炎症、水肿、血肿、血栓症如支气管炎、支气管哮喘、急性肺炎、产后乳房充血、乳腺炎、产后血栓性静脉炎、视网膜炎等，与抗菌药物合用治疗关节炎、关节周围炎、蜂窝织炎、小腿溃疡等均有效。眼科用于治疗视网膜炎。
- Associated Conditions
- Swelling
- Associated Therapies
- Eschar removal
Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease
- First Posted Date
- 2022-02-28
- Last Posted Date
- 2022-02-28
- Lead Sponsor
- Mucpharm Pty Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT05258682
Evaluation of Oral Plaque Removal Utilizing an Adjunct Enzyme Pre-rinse
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-08-13
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- Indiana University
- Target Recruit Count
- 46
- Registration Number
- NCT04512482
- Locations
- 🇺🇸
Indiana University School of Dentistry, Indianapolis, Indiana, United States
BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei
- First Posted Date
- 2019-06-06
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- Mucpharm Pty Ltd
- Target Recruit Count
- 62
- Registration Number
- NCT03976973
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath